UBE2O and nonpapillary renal cell carcinoma: Notably, UBE2O orchestrates EMT in ccRCC by ubiquitinating epithelial markers (e.g., E-cadherin) for proteasomal degradation while concurrently upregulating mesenchymal markers such as N-cadherin and Vimentin.